The arrangement will allow medicines to be built inside the United States from start to finish, Phlow's CEO said.

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine ...

The new funding helps Phlow accelerate its mission to help make ingredients for medicines either considered in short supply ...

Richmond-based pharmaceutical manufacturing company Phlow announced Tuesday that it had secured $37 million in a capital raise.

Phlow’s capital raise announcement came a day after Gov. Glenn Youngkin and British pharmaceutical firm AstraZeneca publicly ...

While Maryland remains a critical R&D hub for AstraZeneca, Virginia’s selection as the manufacturing cornerstone also highlights the state’s rising prominence in advanced pharmaceutical production, ...

The Annual Report and Financial Statements for the year ended 31 March 2025, including the Notice of Annual General Meeting, are attached to this announcement. Alternatively, copies are available on ...

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful close of its Series C financing ...

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful close of its Series C financing round at an increased ...

Phlow's Series C funding coincides with several significant milestones this year, including the two newly operational U.S.-based cGMP manufacturing facilities, capable of producing APIs at both ...

Virginia Tourism Corp. on Thursday announced that it has named Catherine “Cat” Marshburn as vice president of marketing.

Petersburg says quick action by firefighters kept the fire contained to a section of the building’s roof ...